Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

The FDA is tightening Covid-19 vaccine approval, demanding stronger clinical proof for healthy individuals while easing ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

According to the Center for Disease Control and Prevention, Long COVID is a chronic condition associated with a prior ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.